{"id":10253,"date":"2023-11-10T13:29:39","date_gmt":"2023-11-10T12:29:39","guid":{"rendered":"http:\/\/cilcare.com\/?page_id=10253"},"modified":"2025-02-24T11:21:24","modified_gmt":"2025-02-24T10:21:24","slug":"in-vivo-models","status":"publish","type":"page","link":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/in-vivo-models\/","title":{"rendered":"in vivo models (auditory studies)"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

IN VIVO \u30e2\u30c7\u30eb<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u30b7\u30eb\u30b1\u30a2\u3067\u306f\u3001\u8074\u899a\u7814\u7a76\u5206\u91ce\u306e\u767a\u5c55\u306b\u5c3d\u529b\u3057\u3066\u304a\u308a\u3001\u8074\u899a\u969c\u5bb3\u3001\u611f\u97f3\u6027\u96e3\u8074\u3001\u8033\u9cf4\u308a\u3001\u8033\u306e\u708e\u75c7\u3001\u3055\u3089\u306b\u306f\u6162\u6027\u795e\u7d4c\u708e\u75c7\u6027\u75be\u60a3\u306b\u95a2\u9023\u3059\u308b\u8074\u899a\uff0f\u795e\u7d4c\u969c\u5bb3\u306e\u4f75\u5b58\u75c7\u3092\u5305\u62ec\u7684\u306b\u8a55\u4fa1\u3059\u308b\u305f\u3081\u306e\u3001\u5e83\u7bc4\u306a\u691c\u8a3c\u6e08\u307f\u306ein vivo\u30e2\u30c7\u30eb\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u5f53\u793e\u306e\u524d\u81e8\u5e8a\u7814\u7a76\u306b\u304a\u3051\u308b\u5c02\u9580\u77e5\u8b58\u306f\u3001\u591a\u69d8\u306a\u8074\u899a\u72b6\u614b\u306b\u53ca\u3073\u3001\u8074\u899a\u306e\u5065\u5eb7\u306b\u304a\u3051\u308b\u8907\u96d1\u306a\u8ab2\u984c\u306b\u53d6\u308a\u7d44\u3080\u305f\u3081\u306e\u6700\u5148\u7aef\u306e\u30c4\u30fc\u30eb\u3068\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u79d1\u5b66\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u306b\u63d0\u4f9b\u3059\u308b\u3053\u3068\u306b\u8a87\u308a\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u8074\u899a\u969c\u5bb3\u306e\u8907\u96d1\u3055\u3084\u6839\u672c\u7684\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\u3001\u96e3\u8074\u3001\u7cd6\u5c3f\u75c5\u3084\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u3068\u306e\u95a2\u9023\u6027\u3092\u63a2\u6c42\u3055\u308c\u3066\u3044\u308b\u65b9\u3005\u306b\u3068\u3063\u3066\u3001\u5f53\u793e\u306e\u898b\u8b58\u3068\u6280\u8853\u304c\u7814\u7a76\u30fb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u63a8\u9032\u529b\u3068\u306a\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

\u9a12\u97f3\u6027\u96e3\u8074\u304a\u3088\u3073\u30b7\u30ca\u30d7\u30b9\u969c\u5bb3<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u9a12\u97f3\u306b\u3088\u308b\u5916\u50b7\u306f\u3001\u66b4\u9732\u306e\u5f37\u5ea6\u3068\u671f\u9593\u306b\u5fdc\u3058\u3066\u3001\u5185\u8033\u306b2\u7a2e\u985e\u306e\u640d\u50b7\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u4e00\u6642\u7684\u306a\u8074\u529b\u95be\u5024\u306e\u5909\u52d5\uff08TTS\uff09\u306f\u6b63\u5e38\u306b\u623b\u308a\u307e\u3059\u304c\u3001\u30b7\u30ca\u30d7\u30b9\u969c\u5bb3\u3092\u5f15\u304d\u8d77\u3053\u3059\u304b\u3001\u307e\u305f\u306f\u4e0d\u53ef\u9006\u7684\u306a\u96e3\u8074\u306b\u3064\u306a\u304c\u308b\u6c38\u4e45\u7684\u306a\u8074\u529b\u95be\u5024\u306e\u5909\u52d5\uff08PTS\uff09\u3092\u5f15\u304d\u8d77\u3053\u3059\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u30b7\u30eb\u30b1\u30a2\u306e\u30e2\u30c7\u30eb\u306f\u3001\u9178\u5316\u30b9\u30c8\u30ec\u30b9\u3001\u708e\u75c7\u3001\u30a2\u30dd\u30c8\u30fc\u30b7\u30b9\u3001\u7d30\u80de\u6210\u9577\u3001\u30b7\u30ca\u30d7\u30b9\u969c\u5bb3\u3001\u795e\u7d4c\u6804\u990a\u3001\u304a\u3088\u3073\u8074\u899a\u6a5f\u80fd\u969c\u5bb3\u307e\u305f\u306f\u6709\u6bdb\u7d30\u80de\u640d\u50b7\u306b\u304a\u3051\u308b\u518d\u751f\u306b\u95a2\u4e0e\u3059\u308b\u85ac\u5264\u5019\u88dc\u3001\u7d30\u80de\u7642\u6cd5\u304a\u3088\u3073\u907a\u4f1d\u5b50\u7642\u6cd5\u306e\u8a55\u4fa1\u306b\u95a2\u9023\u3057\u3066\u3044\u307e\u3059\u3002<\/p>

  • \u9a12\u97f3\u306b\u3088\u308b\u6c38\u4e45\u6027\u96e3\u8074\uff08PTS\uff09<\/li>
  • \u9a12\u97f3\u306b\u3088\u308b\u30b7\u30ca\u30d7\u30b9\u969c\u5bb3\u304a\u3088\u3073\u4e00\u904e\u6027\u96e3\u8074\uff08TTS\uff09<\/li>
  • \u30e9\u30c3\u30c8\u3001\u30de\u30a6\u30b9\u3001\u30e2\u30eb\u30e2\u30c3\u30c8\u30e2\u30c7\u30eb<\/li>
  • \u4fdd\u8b77\u304a\u3088\u3073\u518d\u751f\u30d7\u30ed\u30c8\u30b3\u30eb<\/li>
  • \u6a5f\u80fd\u7684\u8a55\u4fa1\u9805\u76ee\uff1aABR\u3001DPOAE\u3001\u6ce2\u5f62 I\u89e3\u6790<\/li>
  • \u7d44\u7e54\u75c5\u7406\u5b66\uff1a\u8778\u725b\u56f3\uff08\u6709\u6bdb\u7d30\u80de\u6570\uff09\u3001\u30ea\u30dc\u30f3\u30b7\u30ca\u30d7\u30b9\u6570\u3001\u8778\u725b\u795e\u7d4c\u7bc0\u7d30\u80de\uff08SGN\uff09\u304a\u3088\u3073\u7dda\u7dad\u6570<\/li>
  • RNA\u304a\u3088\u3073\u30bf\u30f3\u30d1\u30af\u8cea\u30a2\u30ec\u30a4<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u5916\u50b7\u306e\u5f37\u5ea6\u5909\u5316\u306b\u4f34\u3046\u9032\u884c\u6027\u306e\u96e3\u8074<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
    \u30e9\u30c3\u30c8\u306b\u304a\u3051\u308b\u5916\u50b7\u5f8c21\u65e5\u76ee\u306b\u6e2c\u5b9a\u3055\u308c\u305f\u8074\u899a\u7d50\u679c\u306e\u4f8b<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    \n\n\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
    \u524d\u30b7\u30ca\u30d7\u30b9\u30de\u30fc\u30ab\u30fcCtBP2\uff08\u7dd1\uff09\u3068\u5f8c\u30b7\u30ca\u30d7\u30b9\u30de\u30fc\u30ab\u30fcHOMER\uff08\u8d64\uff09\u3067\u5171\u67d3\u8272\u3055\u308c\u305f\u5185\u6709\u6bdb\u7d30\u80de\uff08IHCs\uff09\u306e\u4ee3\u8868\u7684\u306a\u5171\u7126\u70b9\u9855\u5fae\u93e1\u753b\u50cf<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u00a0<\/p>

    105 dB\u97f3\u97ff\u5916\u50b7\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u30ea\u30dc\u30f3\u30b7\u30ca\u30d7\u30b9\u6570\u306e\u6e2c\u5b9a<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    \u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u304a\u3088\u3073\u6297\u751f\u7269\u8cea\u306b\u3088\u308b\u8074\u5668\u6bd2\u6027<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    \u8074\u5668\u6bd2\u6027\u3068\u306f\u3001\u7279\u5b9a\u306e\u6cbb\u7642\u85ac\u3084\u305d\u306e\u4ed6\u306e\u5316\u5b66\u7269\u8cea\u304c\u5185\u8033\u7d44\u7e54\u306e\u6a5f\u80fd\u969c\u5bb3\u3084\u7d30\u80de\u5909\u6027\u3092\u5f15\u304d\u8d77\u3053\u3059\u6027\u8cea\u3092\u6307\u3057\u307e\u3059\u3002\u8074\u5668\u6bd2\u6027\u3092\u793a\u3059\u7269\u8cea\u306f200\u7a2e\u985e\u4ee5\u4e0a\u77e5\u3089\u308c\u3066\u304a\u308a\u3001\u4e2d\u3067\u3082\u3001\u5c0f\u5150\u306e\u304c\u3093\u5316\u5b66\u7642\u6cd5\u3067\u4f9d\u7136\u3068\u3057\u3066\u5e83\u304f\u4f7f\u7528\u3055\u308c\u3066\u3044\u308b\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u3084\u3001\u4e00\u90e8\u306e\u611f\u67d3\u75c7\u306e\u6cbb\u7642\u306b\u4f7f\u7528\u3055\u308c\u308b\u30a2\u30df\u30ce\u30b0\u30ea\u30b3\u30b7\u30c9\u7cfb\u6297\u751f\u7269\u8cea\u304c\u4ee3\u8868\u7684\u3067\u3059\u3002<\/p>

    \u8074\u899a\u9069\u5fdc\u75c7\u306b\u304a\u3051\u308b\u521d\u671f\u306e\u6982\u5ff5\u5b9f\u8a3c\u3092\u884c\u3044\u305f\u3044\u5834\u5408\u3084\u3001\u5b9f\u969b\u306e\u81e8\u5e8a\u6295\u4e0e\u3092\u53cd\u6620\u3057\u305f\u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u5316\u5408\u7269\u306e\u9577\u671f\u7684\u52b9\u679c\u3092\u8a55\u4fa1\u3057\u305f\u3044\u5834\u5408\u306b\u3082\u3001\u30b7\u30eb\u30b1\u30a2\u306e\u5805\u7262\u3067\u691c\u8a3c\u6e08\u307f\u306e\u30e2\u30c7\u30eb\u306f\u3001\u8074\u899a\u969c\u5bb3\u306e\u6cbb\u7642\u4ecb\u5165\u306b\u5411\u3051\u305f\u7b2c\u4e00\u6b69\u3068\u3057\u3066\u975e\u5e38\u306b\u6709\u7528\u3067\u3059\u3002<\/p>

    • \u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u3001\u6297\u751f\u7269\u8cea\uff08\u30b2\u30f3\u30bf\u30de\u30a4\u30b7\u30f3\u306a\u3069\uff09\u306b\u3088\u308b\u8074\u5668\u6bd2\u6027\u50b7\u5bb3<\/li>
    • \u30e9\u30c3\u30c8\u3001\u30e2\u30eb\u30e2\u30c3\u30c8\u3001\u30de\u30a6\u30b9\u306b\u304a\u3051\u308b\u6025\u6027\u304a\u3088\u3073\u6162\u6027\u30e2\u30c7\u30eb<\/li>
    • \u967d\u6027\u5bfe\u7167\u3042\u308a<\/li>
    • \u8a55\u4fa1\u9805\u76ee\uff1aABR\u3001DPOAE<\/li>
    • \u7d44\u7e54\u5b66\uff1a\u8778\u725b\u56f3<\/li>
    • \u8840\u6db2\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\uff1a\u5316\u5408\u7269\u76f8\u4e92\u4f5c\u7528<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      \u30e9\u30c3\u30c8\u306b\u304a\u3051\u308b\u30b7\u30b9\u30d7\u30e9\u30c1\u30f3\u6295\u4e0e\u5f8c\u306e16\u300125\u300132 kHz\u3067\u306e\u6709\u6bdb\u7d30\u80de\u55aa\u5931\u3092\u793a\u3059\u4ee3\u8868\u7684\u306a\u514d\u75ab\u67d3\u8272\u753b\u50cf<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
      <\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
      \n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t

      \u30b5\u30ea\u30c1\u30eb\u9178\u8a98\u5c0e\u6027\u8033\u9cf4\u308a<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      \u8033\u9cf4\u308a\u306f\u3001\u5b9f\u969b\u306b\u306f\u5b58\u5728\u3057\u306a\u3044\u97f3\u3092\u77e5\u899a\u3059\u308b\u73fe\u8c61\u3067\u3042\u308a\u3001\u307b\u3068\u3093\u3069\u306e\u5834\u5408\u3001\u96e3\u8074\u3092\u4f34\u3063\u3066\u767a\u751f\u3057\u307e\u3059\u3002\u8033\u9cf4\u308a\u306e\u75c5\u614b\u751f\u7406\u306f\u3001\u5185\u8033\u306e\u7570\u5e38\u3068\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306e\u6a5f\u80fd\u4e0d\u5168\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u307e\u3059\u3002<\/p>

      \u30b7\u30eb\u30b1\u30a2\u306e\u8033\u9cf4\u308a\u30e2\u30c7\u30eb\u306f\u3001\u6bd4\u8f03\u7684\u5909\u52d5\u306e\u5c11\u306a\u3044\u77ed\u671f\u7684\u306ain vivo\u8a66\u9a13\u3092\u53ef\u80fd\u306b\u3057\u307e\u3059\u3002\u4e00\u822c\u7684\u306a\u8033\u9cf4\u308a\u8a98\u767a\u7269\u8cea\u3067\u3042\u308b\u30b5\u30ea\u30c1\u30eb\u9178\u306f\u6570\u6642\u9593\u304b\u3089\u6570\u65e5\u3067\u4ee3\u8b1d\u3055\u308c\u308b\u305f\u3081\u3001\u8033\u9cf4\u308a\u8a98\u767a\u524d\u3001\u8a98\u767a\u4e2d\u3001\u8a98\u767a\u5f8c\u306e\u751f\u7406\u5b66\u7684\u5909\u5316\u3092\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>

      • \u6025\u6027\u30e9\u30c3\u30c8\u30e2\u30c7\u30eb<\/li>
      • \u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\uff1aGPIAS\uff08\u30ae\u30e3\u30c3\u30d7\u524d\u30d1\u30eb\u30b9\u6291\u5236\uff09<\/li>
      • \u305d\u306e\u4ed6\u306e\u8a55\u4fa1\u9805\u76ee\uff1a\u8074\u899a\u904e\u654f\u3001\u96fb\u6c17\u751f\u7406\u5b66\u7684\u691c\u67fb<\/li>
      • \u753b\u50cf\u8a3a\u65ad\uff1a MEMRI\uff08\u30de\u30f3\u30ac\u30f3\u5897\u5f37MRI\uff09<\/li>
      • \u751f\u5316\u5b66\u7684\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        \u30a6\u30a2\u30d0\u30a4\u30f3\u8a98\u5c0e\u6027\u306e\u8074\u795e\u7d4c\u969c\u5bb3<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        \u8074\u795e\u7d4c\u969c\u5bb3\u306f\u3001\u5185\u8033\u304b\u3089\u8133\u3078\u306e\u97f3\u306e\u4f1d\u9054\u306b\u969c\u5bb3\u304c\u751f\u3058\u308b\u8907\u96d1\u306a\u8074\u899a\u969c\u5bb3\u3067\u3059\u3002\u3053\u306e\u72b6\u614b\u306f\u3001\u5185\u8033\u306e\u611f\u899a\u6709\u6bdb\u7d30\u80de\u304b\u3089\u8133\u5e79\u3078\u3068\u97f3\u3092\u4f1d\u3048\u308b\u8074\u795e\u7d4c\u306e\u640d\u50b7\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u307e\u3059\u3002\u4ed6\u306e\u30bf\u30a4\u30d7\u306e\u96e3\u8074\u3068\u7570\u306a\u308a\u3001\u8074\u795e\u7d4c\u969c\u5bb3\u306f\u4e3b\u306b\u8074\u899a\u306e\u795e\u7d4c\u7684\u5074\u9762\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u305f\u3081\u3001\u97f3\u306e\u51e6\u7406\u3084\u8a00\u8449\u306e\u7406\u89e3\u304c\u56f0\u96e3\u306b\u306a\u308a\u307e\u3059\u3002<\/p>

        \u3053\u306e\u30e2\u30c7\u30eb\u306b\u3064\u3044\u3066\u8a73\u7d30\u3092\u3054\u5e0c\u671b\u306e\u65b9\u306f\u3001\u304a\u6c17\u8efd\u306b\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

        \n\t\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        \u305d\u306e\u4ed6\u306e\u75be\u60a3\u30e2\u30c7\u30eb\u304a\u3088\u3073\u30c8\u30e9\u30f3\u30b9\u30b8\u30a7\u30cb\u30c3\u30af\u30e2\u30c7\u30eb<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t

        \u30b7\u30eb\u30b1\u30a2\u306f\u3001\u304a\u5ba2\u69d8\u306e\u30c8\u30e9\u30f3\u30b9\u30b8\u30a7\u30cb\u30c3\u30af\u52d5\u7269\u307e\u305f\u306f\u7279\u5b9a\u306e\u75c5\u614b\u52d5\u7269\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u8074\u899a\u6a5f\u80fd\u306e\u7279\u6027\u8a55\u4fa1\u3092\u5c02\u9580\u3068\u3057\u3066\u304a\u308a\u3001\u4fe1\u983c\u6027\u306e\u9ad8\u3044\u8074\u899a\u30c7\u30fc\u30bf\u3092\u3054\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>

        \u6a5f\u80fd\u7684\u306a\u8074\u899a\u8a55\u4fa1\u304b\u3089\u5256\u691c\u5f8c\u306e\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u3001\u7d44\u7e54\u75c5\u7406\u5b66\u7684\u8a55\u4fa1\u307e\u3067\u3001\u30e2\u30c7\u30eb\u306e\u8868\u73fe\u578b\u89e3\u6790\u306b\u5fc5\u8981\u306a\u4e00\u9023\u306e\u30b5\u30fc\u30d3\u30b9\u3092\u5305\u62ec\u7684\u306b\u3054\u63d0\u4f9b\u3057\u307e\u3059\u3002<\/p>

        \u3053\u306e\u30e2\u30c7\u30eb\u306b\u3064\u3044\u3066\u8a73\u7d30\u3092\u3054\u5e0c\u671b\u306e\u65b9\u306f\u3001\u304a\u6c17\u8efd\u306b\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044\u3002<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

        in vivo models At Cilcare, we are dedicated to advancing the field of auditory research by offering a wide range of validated in vivo models that facilitate the comprehensive assessment of hearing disorders, sensorineural hearing loss, tinnitus, ear inflammation, and auditory neuropathy comorbidities associated with chronic neuro-inflammatory diseases. Our expertise in preclinical research spans across a diverse spectrum of auditory conditions, and we take pride in providing the scientific community with cutting-edge tools and solutions to address complex challenges in auditory health. Whether you are exploring the intricacies of hearing impairment, the underlying mechanisms of tinnitus, or the association between hearing loss and Diabetes or Parkinson\u2019s Disease, we are here […]<\/p>","protected":false},"author":6,"featured_media":0,"parent":9055,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10253","page","type-page","status-publish","hentry","entry"],"yoast_head":"\nin vivo models (auditory studies) - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/in-vivo-models\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"in vivo models (auditory studies) - Cilcare\" \/>\n<meta property=\"og:description\" content=\"in vivo models At Cilcare, we are dedicated to advancing the field of auditory research by offering a wide range of validated in vivo models that facilitate the comprehensive assessment of hearing disorders, sensorineural hearing loss, tinnitus, ear inflammation, and auditory neuropathy comorbidities associated with chronic neuro-inflammatory diseases. Our expertise in preclinical research spans across a diverse spectrum of auditory conditions, and we take pride in providing the scientific community with cutting-edge tools and solutions to address complex challenges in auditory health. Whether you are exploring the intricacies of hearing impairment, the underlying mechanisms of tinnitus, or the association between hearing loss and Diabetes or Parkinson\u2019s Disease, we are here […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/in-vivo-models\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T10:21:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2320\" \/>\n\t<meta property=\"og:image:height\" content=\"975\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"4\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/\",\"url\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/\",\"name\":\"in vivo models (auditory studies) - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png\",\"datePublished\":\"2023-11-10T12:29:39+00:00\",\"dateModified\":\"2025-02-24T10:21:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our missions – External innovation\",\"item\":\"https:\/\/www.cilcare.com\/our-missions-external-innovation\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"in vivo models (auditory studies)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"in vivo models (auditory studies) - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/in-vivo-models\/","og_locale":"ja_JP","og_type":"article","og_title":"in vivo models (auditory studies) - Cilcare","og_description":"in vivo models At Cilcare, we are dedicated to advancing the field of auditory research by offering a wide range of validated in vivo models that facilitate the comprehensive assessment of hearing disorders, sensorineural hearing loss, tinnitus, ear inflammation, and auditory neuropathy comorbidities associated with chronic neuro-inflammatory diseases. Our expertise in preclinical research spans across a diverse spectrum of auditory conditions, and we take pride in providing the scientific community with cutting-edge tools and solutions to address complex challenges in auditory health. Whether you are exploring the intricacies of hearing impairment, the underlying mechanisms of tinnitus, or the association between hearing loss and Diabetes or Parkinson\u2019s Disease, we are here […]","og_url":"https:\/\/www.cilcare.com\/jp\/our-missions-external-innovation\/in-vivo-models\/","og_site_name":"Cilcare","article_modified_time":"2025-02-24T10:21:24+00:00","og_image":[{"width":2320,"height":975,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/","url":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/","name":"in vivo models (auditory studies) - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png","datePublished":"2023-11-10T12:29:39+00:00","dateModified":"2025-02-24T10:21:24+00:00","breadcrumb":{"@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2023\/11\/Auditory-results-in-rat-NIHL-768x323.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/in-vivo-models\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Our missions – External innovation","item":"https:\/\/www.cilcare.com\/our-missions-external-innovation\/"},{"@type":"ListItem","position":3,"name":"in vivo models (auditory studies)"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/10253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=10253"}],"version-history":[{"count":129,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/10253\/revisions"}],"predecessor-version":[{"id":13319,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/10253\/revisions\/13319"}],"up":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/pages\/9055"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=10253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}